Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis, IGA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01225445
What this trial is testing

Treatment of Early Immunoglobulin A Nephropathy by Angiotensin Converting Enzyme Inhibitor - A Randomized Controlled Trial

Who this might be right for
Biopsy-confirmed IgA NephropathyProteinuria Less Than 0.5 g Per DayNormal Blood Pressure+1 more
Chinese University of Hong Kong 60
Not applicableStudy completedNCT06767592
What this trial is testing

Probiotics in IgA Nephropathy

Who this might be right for
IgA Nephropathy
University of Leicester 18
Post-approval studies (Phase 4)UnknownNCT04020328
What this trial is testing

Leflunomide Plus Low Dose Corticosteroid in Immunoglobulin A (IgA) Nephropathy With Renal Insufficiency

Who this might be right for
Glomerulonephritis, IGARenal Insufficiency, Chronic
Shenzhen Second People's Hospital 70
Large-scale testing (Phase 3)Looking for participantsNCT06994845
What this trial is testing

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

Who this might be right for
Primary Immunoglobulin A Nephropathy (IgAN)
Novartis Pharmaceuticals 31
Not applicableUnknownNCT05320133
What this trial is testing

Jinghua Weikang Capsule Containing Quadruple Therapy for IgAN With Helicobacter Pylori Infection

Who this might be right for
Helicobacter Pylori Infection
Peking University First Hospital 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04573478
What this trial is testing

Atrasentan in Patients With IgA Nephropathy

Who this might be right for
IgA NephropathyImmunoglobulin A Nephropathy
Novartis Pharmaceuticals 404
Early research (Phase 1)Study completedNCT06922305
What this trial is testing

Relative Bioavailability Study of HR19042 in Healthy Subjects

Who this might be right for
Primary IgA Nephropathy; Autoimmune Hepatitis
Jiangsu HengRui Medicine Co., Ltd. 18
Not applicableStudy completedNCT04389827
What this trial is testing

Global Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
The George Institute 5,999
Early research (Phase 1)Study completedNCT05562362
What this trial is testing

Study to Evaluate the Pharmacokinetics of Oral Sparsentan Suspension

Who this might be right for
Healthy Subjects
Travere Therapeutics, Inc. 47
Large-scale testing (Phase 3)Study completedNCT04541043
What this trial is testing

Efficacy and Safety in Patients With Primary IgA Nephropathy Who Have Completed Study Nef-301 (Nefigard-OLE)

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 119
Testing effectiveness (Phase 2)Looking for participantsNCT07582133
What this trial is testing

A Trial to Evaluate the Long-term Safety and Tolerability of HRS-5965 in Patients With Primary IgA Nephropathy

Who this might be right for
Primary IgA Nephropathy
Chengdu Suncadia Medicine Co., Ltd. 380
Not applicableActive Not RecruitingNCT07754019
What this trial is testing

Serum and Urinary sCD163 in IgA Nephropathy

Who this might be right for
IgA Nephropathy
Bezmialem Vakif University 87
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Not applicableStudy completedNCT04092491
What this trial is testing

Study of the IgA Repertoire During IgA Deposition Nephropathy.

Who this might be right for
Glomerulonephritis, IGA
University Hospital, Limoges 80
Large-scale testing (Phase 3)Active Not RecruitingNCT05799287
What this trial is testing

Telitacicept for IgA Nephropathy (TELIGAN)

Who this might be right for
Primary IgA Nephropathy
RemeGen Co., Ltd. 318
Not applicableLooking for participantsNCT07074951
What this trial is testing

Tonsillectomy and Immunosuppression in Caucasian Patients With High-risk IgA-nephropathy

Who this might be right for
Primary IgA-nephropathyHigh-riskCaucasians
St. Petersburg State Pavlov Medical University 240
Testing effectiveness (Phase 2)Study completedNCT03945318
What this trial is testing

Safety and Tolerability of BION-1301 in Healthy Volunteers and Adults With IgA Nephropathy (IgAN)

Who this might be right for
IgA Nephropathy
Novartis Pharmaceuticals 103
Not applicableUnknownNCT04805047
What this trial is testing

SodiUm Restriction by Behavioral Intervention

Who this might be right for
IgA Nephropathy
First Affiliated Hospital Xi'an Jiaotong University 142
Testing effectiveness (Phase 2)Study completedNCT05856760
What this trial is testing

Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

Who this might be right for
Immunoglobulin A Nephropathy
Travere Therapeutics, Inc. 48
Large-scale testing (Phase 3)Study completedNCT02062684
What this trial is testing

BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration

Who this might be right for
IgA Nephropathy
Anthera Pharmaceuticals 57
Next Page